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A dual role in regulation and toxicity for the
disordered N-terminus of the toxin GraT
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Bacterial toxin-antitoxin (TA) modules are tightly regulated to maintain growth in favorable
conditions or growth arrest during stress. A typical regulatory strategy involves the antitoxin
binding and repressing its own promoter while the toxin often acts as a co-repressor. Here we
show that Pseudomonas putida graTA-encoded antitoxin GraA and toxin GraT differ from other
TA proteins in the sense that not the antitoxin but the toxin possesses a ﬂexible region. GraA
auto-represses the graTA promoter: two GraA dimers bind cooperatively at opposite sides of
the operator sequence. Contrary to other TA modules, GraT is a de-repressor of the graTA
promoter as its N-terminal disordered segment prevents the binding of the GraT2A2 complex
to the operator. Removal of this region restores operator binding and abrogates Gr
aT toxicity. GraTA represents a TA module where a ﬂexible region in the toxin rather than in
the antitoxin controls operon expression and toxin activity.
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Toxin–antitoxin (TA) modules, the small genetic elementsbelieved to be involved in prokaryotic stress response1–3,are widespread among both archaea and bacteria4,5. Six
major types (I–VI) of TA systems have been discovered so far6. In
each type, the toxin is a protein that interferes with vital cellular
processes, but the nature and mode of action of the antitoxin
varies. The antitoxin either prevents production of the cognate
toxin as an antisense RNA (type I) or as an RNase that degrades
the mRNA encoding the toxin (type V), counteracts the activity
of the toxin as a protein (type II) or RNA species (type III) that
binds to the toxin, acts as an antagonist for the toxin by com-
peting with its target (type IV) or functions as a proteolytic
adaptor that promotes degradation of the toxin (type VI). Of
these, type II systems with protein antitoxins are the most
abundant and widely researched1.
The production of type II TA proteins is auto-regulated at the
level of transcription. Their antitoxins are typically composed of
two domains: a DNA binding domain next to an (often intrin-
sically disordered) toxin neutralizing domain7. The DNA binding
domain interacts with the operator to inhibit transcription of the
TA operon. For many type II TA systems (e.g., phd/doc, ccdAB,
relBE and kis/kid) repression depends on the ratio between toxin
and antitoxin by a mechanism known as conditional coopera-
tivity8–10. At low toxin/antitoxin molar ratios, the toxin enhances
the antitoxin gene repression, but when a certain threshold ratio
is surpassed, the toxin becomes a derepressor. This behavior is
generated in different TA modules via distinct molecular
mechanisms11–14. Nevertheless, other type II TA systems such as
Escherichia coli dinJ/yafQ, Proteus vulgaris higBA or E. coli
mqsRA are not regulated by conditional cooperativity15–17. In the
ﬁrst two cases the toxin does not affect binding of the antitoxin to
the operator. For the latter, the toxin disrupts the antitoxin-
operator complex.
GraTA (Growth rate affecting Toxin–Antitoxin) is a type II
TA module recently discovered in Pseudomonas putida18.
By sequence similarity, GraTA is most closely related to the
higBA TA family18. The toxin GraT has a very mild effect at the
optimal growth temperature of 30 °C or higher and this allows
for the deletion of the antitoxin graA gene from the chromosome.
At lower temperatures, however, GraT causes severe growth
repression18. GraT inhibits ribosome biogenesis and causes the
accumulation of nearly complete yet immature ribosome
subunits19. The antitoxin GraA binds to the graTA promoter and
effectively represses transcription of the operon18. GraA is an
unusually stable protein in comparison to most TA antitoxins
with a minimal observed half-life of 1 h in cell lysate. It is not
degraded by either Lon or Clp that commonly target antitoxins.
Instead, its degradation is initiated by an unidentiﬁed endopro-
tease20. These properties of the antitoxin result in very efﬁcient
inhibition of GraT even when the toxin is ectopically
overexpressed18.
Most type II antitoxins contain an intrinsically disordered
region that is required not only for neutralizing the toxin and
forming the repressor complex7,21 but also for its rapid degrada-
tion22 and for the dissociation of the toxin from its target
(e.g., CcdB and Gyrase)7,13. On the contrary, all toxins char-
acterized to date are fully folded proteins7. Here we show that
GraA does not contain unstructured regions and forms a globular
dimer while the toxin GraT contains an N-terminal intrinsically
disordered region that is key for transcriptional regulation of the
graTA operon as well as for the RNase activity of GraT. GraA
binds tightly to the graTA operator and GraT prevents this
interaction through steric interference from its N-terminal dis-
ordered region. Removal of this region restores operator binding,
and also abrogates GraT toxicity. GraTA thus represents a type of
TA module where intrinsically disordered region in the toxin
rather than in the antitoxin controls both operon expression and
toxin activity.
Results
GraA is a fully folded antitoxin. The crystal structure of GraA
was determined at 1.96 Å (Fig. 1a and Supplementary Table 1).
The protein was completely traced and, in contrast to other
antitoxins, does not contain an intrinsically unfolded domain.
GraA forms a homo-dimer (from now on referred to as GraA2).
The GraA monomer consists of one long and four short (2–3
turns) α-helices, of which helices α2 and α3 form a helix-turn-
helix (HTH) motif (Fig. 1a). Helix α5 extends over seven turns to
form a dimerization unit and its C-terminus (after a kink) also
caps over the globular domain of the other monomer.
The fold of GraA is similar to that of the HigA antitoxins from
E. coli (Protein Data Bank (PDB) codes, 2ICT and 2ICP)23,
Coxiella burnetti (PDB code 3TRB)24 and P. vulgaris (PDB code,
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Fig. 1 Structure of the GraA dimer. a. Cartoon representation of GraA2, one monomer is colored sand and the other is in purple. The ﬁve α-helices are
labeled from α1 to α5. N- and C-termini are labeled. The helix-turn-helix (HTH) motifs are highlighted in red, and the distance between both motifs,
measured as the distance between the centers of mass of both α3 helices, is indicated. b Van der Waals surface of the GraA dimer colored according to its
electrostatic surface potential (10 kT blue, 0 white, −10 kT red) in two orientations rotated by 180°. The orientation on the left corresponds to the same
orientation as in (a). The DNA binding surface shows a prominent positive electrostatic potential (indicated by a blue circle) while the GraT binding site,
located at the opposite side of the GraA2 dimer, is negatively charged (indicated by a black circle)
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4MCX)16. The closest homolog with known structure for GraA
is C. burnetti HigA (backbone root-mean-square deviation
(RMSD) of 2.6 Å for residues 4–99 when superimposing
monomers). For P. vulgaris HigA, which is characterized in
more detail and with which it shares 27% sequence identity, the
backbone RMSD is 3.0 Å for residues 4–99 (Supplementary
Figure 1A, B).
The dimerization interface of GraA2 is mainly stabilized by
hydrophobic interactions. The helix-turn-helix DNA binding
motif, comprising residues from 25 to 45, presents a positively
charged surface (Fig. 1b). The separation between the two
HTH motifs in the dimer, measured as the distance between the
centers of mass of both α3 helices, is 33.8 Å (Fig. 1a). Other
antitoxins with known structure and bearing HTH DNA binding
motifs are the three HigAs mentioned above, E. coli MqsA25, and
the HipBs from E. coli26 and Shewanella oneidensis27 (PDB
entries 3O9X, 3DNV and 4PU3, respectively). From these
antitoxins only E. coli HigA has a similar separation between
the two HTH motifs of 35 Å, while in the HipB and MqsA dimers
the HTH motifs are much closer to each other (~26 Å).
Two GraA2 bind simultaneously on the operator DNA. GraA
represses the graTA operon by binding to its operator18. We
determined the crystal structure of GraA2 in complex with the
full 33 bp operator at 3.8 Å resolution (Supplementary Table 1).
Surprisingly, in the crystal two non-interacting GraA dimers bind
at opposite sides of the double helix (Fig. 2a, Supplementary
Figure 2A, B). The total buried surface area between the two
GraA dimers and the DNA is 2234 Å2. This interface is evenly
distributed among the four partial interfaces formed between
each of the four GraA monomers and the DNA strands, with an
average value of 558 Å2 per GraA monomer.
GraA2 reads the operator in a very particular way. Each GraA2
has one of its HTH motifs interacting with the central
TAACGTTA palindrome (Fig. 2b). This “central binding” HTH
motif binds with its interaction helix α3 to a TAAC half
palindrome. This interaction involves Pro39 protruding into
the major groove of the DNA, while Arg46 and Asn42 make
hydrogen bonds with the DNA backbone (Fig. 2c). No hydrogen
bonds between the protein and the DNA bases are observed. This
central binding mode is identical for each of the two bound
dimers.
The other HTH motifs of each GraA2 act as the “support”
subunits and interact with two distal half sites with sequences
TAAG and TAAC, respectively (Fig. 2b). In these distal half sites
the interaction is again directed towards the DNA phosphate
backbone, and no base-speciﬁc contacts are made between
protein and DNA.
The operator binding does not signiﬁcantly inﬂuence the
structure of GraA2. A monomer backbone RMSD of 1.2 Å
is observed between the bound and unbound states of GraA
dimer. Binding does not affect the conformation of the GraA
monomer nor the relative position or orientation of the
monomers in the dimer. The DNA structure also does not
deviate much from the ideal B-DNA conformation and no
signiﬁcant bending is observed. In contrast, the shorter
distances between the binding helices in HipB and MqsA induce
bends in the DNA of 55° and 70°, respectively25–27 (Supplemen-
tary Figure 2C, D).
GraA interactions with the distal sites are non-speciﬁc. Iso-
thermal titration calorimetry (ITC) experiments between GraA2
and the 33 bp operator fragment point towards a 2:1 stoichio-
metry in agreement with the crystal structure and indicate a
macroscopic binding constant of 3 × 1013 M−2 (Table 1 and
Supplementary Figure 3A). To further understand the speciﬁcity
of GraA2 to its operator, we performed a series of ITC mea-
surements titrating different mutant variants of the operator
region into GraA2 (Table 1 and Supplementary Figure 3). GraA2
displays 102 to 104 times lower afﬁnities for operators with
mutated palindrome sequences TAACGggc, gccCGTTA and
TAgtGTTA (Table 1 and Supplementary Figure 3B, C, D). This
conﬁrms the central palindrome as a major binding motif within
the operator. However, GraA2 was insensitive (<10-fold decrease
in afﬁnity) to all tested operator variants with substitutions in the
secondary binding sites outside the central palindrome (Table 1
and Supplementary Figure 3E, F, G). Interestingly, making the
operator symmetric based on either the sequence of the left or
right side of the central palindrome reduces the afﬁnity for GraA
10-fold (Table 1 and Supplementary Figure 3H, I). We thus
conclude that despite the absence of base-speciﬁc hydrogen bonds
between protein and DNA, the interactions between GraA2 and
the operator central palindrome is sequence speciﬁc. In contrast,
the interactions of the second HTH motif of each GraA2 dimer
Table 1 Thermodynamics of operator binding
Operator variant Sequencea,b KA (M−2) ΔH (kcal/mol)
Wild type AAATTAACGAATAACGTTAAGCATTCAGCTCAT 3.0*1013 ± 3.1*106 −19.0 ± 1.5
Variant 1 AAATTAACGAATAACGggccGCATTCAGCT 2.1*109 ± 5.2*106 N.D.c
Variant 2 AAATTAACGAAgccCGTTAAGCcggCAGCT 4.7*1011 ± 1.4*105 −5.2 ± 0.6
Variant 3 AAATTAACGAATAgtGTTAAGCATTCAGCT 3.9*1011 ±
7.0*104
−5.6 ± 0.3
Variant 4 AAAggcACGAATAACGTTAAGCATTCAGCT 4.3*1013 ±
3.5*105
−14.6 ± 0.5
Variant 5 AAATTAACGccgAACGTTAAGCATTCAGC 7.1*1012 ± 4.5*105 −15.4 ± 0.8
Variant 6 AAATTAACGAATAACGTTAAGCcggCAGCT 1.5*1013 ± 5.4*105 −14.8 ± 0.9
Left side mirrored AAATTAACGAATAACGTTAttcgttaattt 5.2*1012 ±
5.5*105
−23.4 ± 1.5
Right side mirrored agctgaatgctTAACGTTAAGCATTCAGCT 3.5*1012 ±
7.7*105
−26.7 ± 2.2
Central palindrome GAATAACGTTAAG N.D. N.D.
Upstream half AAATTAACGAATAACGTTAAG N.D. N.D.
Downstream half AATAACGTTAAGCATTCAGCT N.D. N.D.
aMutations relative to the wild-type sequence are given in small letters
bPosition of the Palindromic sequence is marked in bold
cNot determined (N.D.) because binding was too weak
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with the distal binding sites only contribute weakly if at all to
speciﬁcity.
Operator binding by GraA is highly cooperative. Electro-
phoretic mobility shift assays (EMSAs) of the 33 bp operator
fragment with GraA2 conﬁrm the 2:1 (GraA2/operator) stoi-
chiometry, but fail to reveal a two-step binding process as only a
single band for the operator complex can be detected (Fig. 2d).
This suggests that binding of two GraA2 dimers to its operator is
highly cooperative and occurs via a tri-molecular reaction. To
evaluate this hypothesis, we performed a series of analytical size
exclusion chromatography (SEC) experiments using different
GraA2/DNA ratios (Fig. 3a). In all SEC runs, independent of the
stoichiometry of the initial mixture, only a single species of
GraA2/DNA complex was observed. This species has an apparent
molecular weight of about 70 kDa, consistent with two GraA
dimers binding coincidently to the operator ((GraA2)2/DNA). No
intermediate species with GraA2/DNA stoichiometry is detected.
These results were subsequently conﬁrmed by similar titrations
followed via native mass spectrometry. Again, free DNA, free
GraA2 and the (GraA2)2/DNA complex were the only species that
could be identiﬁed (Fig. 3b, Supplementary Figure 4).
To further quantify the apparent cooperativity in the GraA-
operator interaction, we performed ITC titrations with shorter
versions of the operator comprising only the central palindrome
or the palindrome plus its “upstream half-site” or its “down-
stream half-site” (Table 1 and Supplementary Figure 3J, K, L).
These experiments show that the upstream and downstream half
sites are both essential for operator binding and that a single
GraA dimer will not, on its own, interact with an operator
fragment even if the full sequence that is recognized by a single
GraA dimer is present.
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Fig. 2 GraA2 binds to its operator with a 2:1 stoichiometry. a Cartoon representation of the GraA2-DNA-GraA2 complex with the GraA monomers colored
as in Fig. 1a. Two GraA dimers are bound at opposite sides of the DNA duplex without making physical contact to each other. b Schematic representation of
GraA-DNA binding. The central palindrome that provides the two speciﬁc half sites is shown in blue and boxed. The two half sites on the DNA that provide
non-speciﬁc but necessary contacts are colored green. c Zoom-in to the central GraA2-DNA-GraA2 binding interface. Amino acids that make direct contact
with the DNA are shown in stick and labeled. Hydrogen bonds are shown as dashed lines. d Electrophoretic mobility shift assay (EMSA) experiment
titrating GraA on the same 33 bp DNA fragment as used for crystallography. Only a single species of protein-DNA complex is apparent. The DNA is
saturated in a 2:1 molar ratio of GraA2 to DNA
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08865-z
4 NATURE COMMUNICATIONS |          (2019) 10:972 | https://doi.org/10.1038/s41467-019-08865-z | www.nature.com/naturecommunications
While the two GraA dimers come close together on the
operator, they do not effectively touch each other, and
oligomerization of GraA2 therefore can be excluded as a driving
force for the apparent obligatory co-incident binding. Coopera-
tivity is therefore mediated entirely via the common DNA ligand,
although the exact mechanism remains obscure.
GraTA architecture deviates from the P. vulgaris HigBA.
We determined the structure of the GraTA toxin–antitoxin
complex at 2.2 Å resolution (Supplementary Table 1, Fig. 4a).
With one His-tagged GraT monomer bound to each GraA
monomer, a GraT-GraA2-GraT hetero-tetramer (hisGraT2A2 for
short) is formed. The structure of GraT is similar to P. vulgaris
HigB (PDB entry 4MCX) with a backbone RMSD of 2.5 Å for
residues 23–92 and a sequence identity of 29% (Supplementary
Figure 1B, C).
Binding of GraT does not affect the structure of the GraA
monomer but the relative orientation of each monomer in the
GraA dimer is somewhat displaced. Upon binding of GraT, there
is a 2.2° relative rotation of the GraA helix α3, which results in a
1.6 Å decrease of the distance between the HTH motifs
(Supplementary Figure 5A–D).
GraT binds on a negatively charged surface area of GraA,
which is located opposite to the DNA binding surface (Fig. 1b).
The contact surface area of one GraT monomer with GraA2 is
488 Å2. In GraT, residues S27, E30, R31, K32, A38, R43, D44, S47
and G50 are involved in hydrogen bonds with the GraA residues
R7, E13, E18, D64, T66 and N72 (Fig. 4b). Hydrophobic
interactions are also important for the GraA-GraT binding. In
particular, A34, M35, A38, A39, P48 and P49 of GraT interact
with a hydrophobic pocket on the surface of GraA formed by I9,
I14, F19, M23, L63, F69 and L73.
Based on extrapolation from the structure of HigB in complex
with the ribosome28 (PDB entry 4W4G), the active site of GraT,
formed by a cleft around His92, is not occluded by GraA. Instead,
GraA inactivates GraT by inhibiting its binding to the ribosome
due to steric hindrance via clashes between GraA and the
ribosomal RNA as well as ribosomal protein S13 (Supplementary
Figure 5E).
Despite their structural similarities, the relative orientations
of the toxin and antitoxin in the GraTA complex are different
from what is seen in the P. vulgaris HigBA complex16. When both
antitoxins are superimposed, the bound toxins GraT and HigB
show a relative rotation of about 25° and their centers of mass
are displaced by 6.8 Å (Fig. 4c). Still, about 30% of the GraA
residues involved in the GraA–GraT interface are conserved in
P. vulgaris HigA (Supplementary Figure 1B). In contrast, none
of interface residues of GraT are conserved in P. vulgaris HigB
(Supplementary Figure 1B).
The N-terminus of GraT is intrinsically disordered. Another
major difference between the graTA and the P. vulgaris higBA
modules concerns the N-termini of the toxins. In P. vulgaris
HigB the N-terminus is well deﬁned, both in the free state of
HigB28 and when bound to HigA16 (PDB entries 4PX9 and
4MCX, respectively), and also when bound to the ribosome
(PDB entries 4YPB and 4W4G)29. In GraT, on the other
hand, the ﬁrst 22 N-terminal residues together with the 6-His
tag are located in an interstitial space and could not be traced
due to lack of electron density. These 22 residues do not corre-
spond to an extension that is absent in P. vulgaris HigB, but
to a stretch that is common to both proteins (Supplementary
Figure 1B). In P. vulgaris HigB, this region folds into a strand-
helix-loop structure. Of this fold, the N-terminal β-strand is
conserved in E. coli RelE but the short α-helix is present in a
different orientation12.
In order to validate that the intrinsically disordered N-
terminus of GraT is indeed retained in solution and not an
artifact of crystal packing or His-tag placement, we designed a
tag-free construct of the GraT2A2 complex that was further
analyzed by small-angle X-ray scattering (SAXS).
To obtain the tag-free GraT2A2 complex, a TEV (tobacco etch
virus) protease cleavage site was inserted in between the 6-His tag
and the second residue of GraT (ΔHisGraT2A2). The tag-free
GraT2A2 complex only differs from wild-type GraT2A2 by having
a glycine instead of a methionine as the ﬁrst residue of GraT.
At ﬁrst glance, the dimensionless Kratky plot of GraT2A2
shows that the complex is globular (Fig. 5a). Nevertheless, as the
predicted disorder part is only 11% of the full complex and might
not be captured by the SAXS experiment, we wanted to know
which possible conformation of GraT2A2 best ﬁts the
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Fig. 3 GraA2 binding to the operator is highly cooperative. a Analytical size
exclusion proﬁles for different GraA2:operator molar ratios using a constant
DNA concentration of 10 μM, in a 70 kDa cut-off Bio-Rad SEC 70 column.
The inset shows the column calibration curve using molecular weight
standards (ovalbumin 44 kDa, myoglobin 17 kDa, vitamin B12 1.35 kDa,
open red circles on inset) together with the elution positions for GraA2 and
(GraA2)2-operator complex (black dots on inset). b Native mass spectrum
for a mixture of operator (20 μM of duplex) and GraA2 (20 μM of dimer).
The observed species correspond to the operator duplex, GraA2 and
(GraA2)2-operator complex
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experimental scattering data: a model with a disordered N-
terminus or a model with the N-terminus folded as in P. vulgaris
HigB. For the former option we used the online program
MultiFoxs62. By deﬁning the ﬁrst 22 amino acids of GraT as
disordered (ﬂexible), this software generated 10,000 conforma-
tions from where it selected a four-states model as the best ﬁt to
the experimental scattering curve with a χ2= 1.4 (Fig. 5b, blue
curve). This four-states model shows an Rg distribution with one
major peak from 21.5 to 24.5 Å with weight of 0.86 (Supplemen-
tary Figure 6A). For the latter option, we modeled the 22 N-
terminal amino acids in the conformation displayed by the
corresponding segment of P. vulgaris HigB and kept the
remainder of GraT as in the GraT2A2 crystal structure, and
again compared this model to the experimental scattering curve
(Fig. 5b, red curve). In this case the ﬁtting of the theoretical to the
experimental scattering curve was worse with a χ2= 10.5. All this
together suggests that despite the shape of the dimensionless
Kratky plot, the N-terminal segment of GraT might indeed be
disordered but is not picked up in this plot because this region
only represents 10% of the protein complex.
To corroborate the previous hypothesis, we expressed and
puriﬁed and inactive form of the toxin. This form consists of
the substitution of the C-terminal H92 by a TEV cleavage
site followed by a histidine tag (ENLYFQGSAGHHHHHH).
After proteolysis with TEV this new version of GraT is only
ﬁve amino acids longer than the wild type (<6% difference). In
this case, the dimensionless Kratky plot (Fig. 5c) shows a slight
disorder with a small shift of the maximum towards higher values
(2.0; 1.22) with respect to the maximum for globular proteins
with coordinates (1.73; 1.1). Furthermore, the theoretical
scattering curve of the disordered ensemble ﬁts much better the
experimental scattering curve than the HigB-like conformation
(Fig. 5d), with χ2= 3.1 and 8.9, respectively. In this case, the
ensemble consists on a four-state model with a major peak in
the Rg distribution from 13 to 15 Å with a weight of 0.8 and
three other small peaks at larger Rgs with weights smaller than 0.1
(Supplementary Figure 6B).
The GraT N-terminus is required for mRNase activity. The P.
vulgaris HigB has been shown to cleave mRNAs in a ribosome-
dependent manner29. Thus, we tested whether GraT is also an
mRNAse and whether the N-terminal region is required for its
functionality. We overexpressed GraT and a truncated version of
GraT without the ﬁrst 22 residues (Δ22GraT) in E. coli and
analyzed the highly abundant lpp mRNA for degradation. To
avoid possible cross-activation of E. coli chromosomal TA sys-
tems in response to GraT expression, the primer extension of the
lpp mRNA was carried out in the E. coli mRNase-deﬁcient Δ10
TA strain30. As plasmids carrying only the graT gene were toxic
even without induction, we modiﬁed the graTA operon by
replacing the native Shine–Dalgarno (SD) sequence in front of the
graT with a more effective SD from the pET11c expression
plasmid. This strong SD sequence in the constructed pBBRlacI-
tac-graTA plasmid enables expression of GraT at a higher level
than GraA, and causes an inducible cold-dependent growth defect
in E. coli. Notably, expression of Δ22GraT was not inhibitory to
E. coli growth. GraT induction results in a distinct cleavage pat-
tern on lpp mRNA, which is not detected in non-induced samples
Fig. 4 Structure of the GraTA complex. a Cartoon representation of the
GraTA complex, which shows a GraT-GraA2-GraT architecture. GraT is
colored in blue and GraA colored as in Fig. 1a. N- and C-termini are labeled.
The direction of the disordered extension at the N-terminus of GraT is
indicated by a dashed line. b Zoom-in of the GraT-GraA interface. Residues
which are at less than 4 Å from the other molecule are represented in stick
and labeled. Colors are as in (a). Hydrogen bonds are shown as dashed
lines. c Superposition of a single GraA-GraT unit from the GraTA complex
on an equivalent HigA-HigB unit from P. vulgaris HigBA. GraA and GraT are
colored as in (a). HigA is in gray while HigB is in pink. The 25° relative
rotation of both toxins is clearly visible
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(Fig. 6, source data are provided as a Source Data ﬁle). Most of
the observed cut sites are located between the 2nd and 3rd
nucleotides of codons with adenine in the 2nd position. The only
exception is the 10th cleavage (Fig. 6), which is found between
two codons but still following an A nucleotide. Strong codon
dependence suggests that, like other HigB family toxins, GraT
acts as a ribosome-dependent mRNase. Given that induction of
Δ22GraT did not result in mRNA cleavage (Fig. 6), the N-
terminal disordered region is necessary for GraT mRNAse
activity.
In order to conﬁrm this result in P. putida, we constructed the
Δ22graT derivative strains from P. putida wild-type and ΔgraA and
compared the bacterial growth at different temperatures. GraT
inhibits growth of P. putida at 20 °C in the absence of GraA, while
at higher temperatures, growth is gradually restored (Supplemen-
tary Figure 7). The Δ22graT-encoding strains grow just like the
wild-type P. putida, independently of the presence of the graA
gene. Thus, GraT-mediated growth arrest in P. putida requires the
full-length protein including its disordered N-terminus.
GraT disorder prevents GraTA binding the operator in vitro.
GraA2 strongly binds to its operator in a 2:1 molar ratio (Kmacro
= 3.1 × 1013 M−2, Table 1, see above). By contrast, the macro-
scopic binding constant of the GraT2A2 complex for its operator
as determined by ITC is signiﬁcantly lower (Kmacro < 107 M−2)
(Fig. 7a). This was not expected because superimposition of the
GraT2A2 complex onto the GraA2-DNA-GraA2 complex shows
that GraT binds to GraA at an opposite side relative to the DNA
binding site of GraA (Fig. 1b), and that there is no direct steric
interference between GraT and the DNA (Supplementary
Figure 8).
Two structural properties of the GraT2A2 complex may
contribute to the low afﬁnity of GraT2A2 for the operator: (1)
the 2.2° re-orientation of the two GraA monomers when bound
to GraT (together with a possible function-interfering alteration
in the dynamics of GraA2 upon GraT binding), and (2) the
presence of the intrinsically disordered segment at the N-
terminus of GraT. To distinguish between these possibilities, we
tested the binding of Δ22GraT2A2 (where GraT is lacking the ﬁrst
22 residues) to the graTA operator using ITC (Fig. 7b).
Δ22GraT2A2 binds to the operator even tighter (Kmacro= 2.3 ×
1015 M−2) than GraA2 alone (Kmacro= 3.1 × 1013 M−2, Table 1),
indicating that GraT does not lock GraA2 into a binding-
incompetent conformation. EMSAs using different (GraT2A2 or
Δ22GraT2A2):operator molar ratios further conﬁrm that in
contrast to the wild-type GraT2A2, the Δ22GraT2A2 complex
readily binds the graTA operator (Fig. 7c, d). These experiments
suggest that the intrinsically disordered N-terminus of GraT is
directly responsible for impairment of operator binding, likely via
steric hindrance.
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GraTA overexpression derepresses the graTA promoter in vivo.
The role of GraT in derepression of the graTA promoter was
further tested in vivo. The graT-lacZ transcriptional fusion was
used as a reporter for graTA promoter activity in E. coli. The
genes coding for GraTA, GraA or Δ22GraTA were cloned under
an isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible tac
promoter. For enabling expression of GraT at a higher level than
GraA, the native SD sequence in front of graT was replaced with
strong SD from the pET11c expression plasmid. Note that for
expression of the GraTA complex, the same plasmid was used as
Min post
Induction
Ipp 5′ end
GraT- cleaved
Codon
1 AAA
2
3
4
5
6
7
8
9
10
11
12
13
14
15
AA|A
CA|G
GA|C
CA|G
AA|A
CA|G
AA|C
GA|C
GCA|
GA|C
CA|G
AA|A
GA|T
GA|C
Empty vector GraT+A
0.5 mM IPTG
T A C G
0 30 60 0 30 60 0 30 60 0 30 60
Empty vector GraT+A
No IPTG
AT C GΔ22GraT Δ22GraT
0 30 60 0 30 60
Fig. 6 The disordered N-terminus of GraT is required to cleave mRNA. Autoradiography of the E. coli lpp mRNA primer extension analysis. MG1655 Δ10TA
cultures carrying either the empty vector pBBRlacItac, pBBRlacItac-graTA or pBBRlacItac-Δ22graT were sampled 0, 30 and 60min after GraT induction at
20 °C (non-induced samples are included as controls). Inducing the full GraT but not the Δ22 mutant variant causes mRNA cleavage. The cut sites follow
adenines, usually in the 2nd position of codons. Cleaved codons are shown next to the gel image with cleavage sites, if precisely determined, represented
by vertical lines
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in the mRNase assay. The plasmids were independently trans-
formed into E. coli already containing the graT-lacZ reporter.
β-Galactosidase measurements show that while GraA alone
represses the graTA promoter activity, the expression of the
GraTA complex leads to full derepression of the promoter
(Fig. 8a, source data are provided as a Source Data ﬁle).
Expression of the Δ22GraTA with N-terminally truncated GraT
again represses the promoter (Fig. 8a), which is in good accor-
dance with strong binding of Δ22GraT2A2 to the operator
(Fig. 7). Expression of the antitoxin and toxin proteins was
veriﬁed by western blot (Fig. 8b). These results conﬁrm the
in vitro data that the GraT N-terminal segment is hindering
the binding of GraTA complex to the operator and that GraT
acts as a derepressor of the graTA operon transcription.
Discussion
In Eukaryotes, many proteins contain long stretches of functional
unstructured regions that vary in size from dozens to hundreds
of amino acids. This lack of structure allows for activities that
are difﬁcult to perform by well-folded proteins. Typical intrinsic
disorder-speciﬁc functions involve hub proteins moonlighting
different tasks31,32, the separation of afﬁnity and speciﬁcity in
folding-upon-binding events33,34, molecular clocks35,36 and
springs37, entropic barriers and counting of phosphate groups38.
Intrinsic disorder is common within transcription regulators in
Eukaryotes39,40. In transcription factors from Prokaryotes, intrinsic
disorder is abundantly present in antitoxins from toxin–antitoxin
modules7,21. The majority of structurally characterized antitoxins
contain a disordered region that neutralizes its toxin counterpart
by folding upon binding. This region is also crucial to allow rapid
degradation of the antitoxin upon activation of Lon or ClpXP
proteases as initially observed for F-plasmid CcdA41,42 and later for
many other antitoxins7,21,22. In the case of the well-studied phd/doc
module from bacteriophage P1, the intrinsically disordered segment
at the C-terminus of Phd prevents the binding of two Phd dimers
adjacent to each other on the operator in the absence of Doc via a
mechanism of entropic exclusion43. This feature helps to enhance
the effect of conditional cooperativity10,11, the mechanism that
tightly regulates the TA operon transcriptional activation prevent-
ing random expression of toxin44–46.
Different from many other TA loci, the graTA operon is not
regulated by conditional cooperativity. GraA alone is responsible
and sufﬁcient for operon autorepression, while the toxin GraT
leads to transcriptional derepression when it binds the antitoxin.
This behavior of GraT resembles that of E. coli toxin MqsR which
also destabilizes the antitoxin-DNA complex17, yet the molecular
mechanisms of two toxins differ. For MqsA, binding to DNA or
to the toxin is mutually exclusive because the DNA and toxin
binding sites overlap on the antitoxin17. In contrast, the binding
sites of GraA for toxin and DNA are located at opposite surfaces
of the protein.
The GraTA module is also unique in that the toxin contains an
intrinsically disordered segment that is involved in regulation of
0
–2
–4
–6
–8
–8
2
0
–2
–4
–6
–10
–12
–14
–16
–18
–20
–22
–24
0.0 0.5 1.0 1.5
kc
al
/m
ol
 o
f i
nje
cta
nt
0.0 0.5
Molar ratio
1.0 1.5
kc
al
/m
ol
 o
f i
nje
cta
nt
KA < 107 M–2
KA = 2×1015 M–2
+
Molar ratio
+
a
b
GraTA2 (μM)
Δ22GraTA2 (μM)
Operator (μM)
0
5 5 5 5
0.62 1.25 2.5 5 10 20
5 5 5Operator (μM)
0 0.62 1.25 2.5 10 20
5
5
5 5 55 55
c
d
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transcription. The 22 N-terminal residues of GraT are disordered
in both the isolated state and the GraTA complex and prevent
the TA complex from interacting with the operator. Given that
the N-terminally truncated version of GraT does not prevent the
interaction of GraA with its operator, the 22-amino-acid intrin-
sically disordered sequence at the N-terminus of GraT seems to
be a major contributor to the inability of the GraT-GraA complex
to bind its target DNA sequence. The charge distribution of this
segment does not seem to be responsible for the GraT-DNA
repulsion. Out of these 22 residues, only 6 are charged, 4 posi-
tively and 2 negatively, yielding a net charge of +2, which would
actually attract the negatively charged DNA. On the other hand,
this disordered stretch is more likely to work as an entropic
barrier that sterically impedes the formation of the GraT2A2-
DNA complex. The N-terminus of the globular part of GraT in
a virtual GraTA-DNA complex points towards the DNA (Sup-
plementary Figure 8), and binding of the GraTA complex to
the operator would heavily restrict the conformational ensemble
that can be adopted by the disordered GraT N-terminus.
Interestingly, while the overall structures of GraA and GraT are
highly similar to the HigA and HigB proteins of P. vulgaris16, the
N-terminal segment in the HigB toxin is, differently from GraT,
fully structured. This ordered HigB N-terminus does not prevent
interaction of HigBA with the operator as it folds back in the
opposite direction, contacting the N-terminus of HigA16. This
structural divergence between the two toxins results in different
outcome in transcription regulation, as HigB does not inhibit
HigA binding to the higBA operator16. This vividly demonstrates
the importance that intrinsically disordered regions play in pro-
tein functionality.
Binding of GraA to its operator is highly cooperative. Inter-
estingly, this cooperativity functions via a communication path-
way involving only the DNA partner and without direct contacts
between the two bound GraA dimers. It has been described that
the mechanical properties of DNA indeed allow for transmission
of allosteric effects via local distortions of the major groove (and
to a lesser extent the minor groove)47. The DNA distortions
that affect the binding dissociation kinetics are dampened as a
function of the distance between the proteins bound to the
DNA47. QacR and PA2196 are two transcriptional regulators of
the TetR family, for which such effects are well documented and
that show the same arrangement as GraA2 when bound to
DNA48,49 (Supplementary Figure 9). Their interaction with DNA
also involves cooperativity between two non-interacting dimers,
and this cooperativity is achieved via a 4 Å stretching of the
DNA48,49. However, GraA2 does not induce any signiﬁcant
deformation in the operator region within experimental errors.
Allostery is thus likely mediated by an accumulation of relatively
small DNA deformations and/or changes in DNA dynamics.
The N-terminal 22-amino-acid segment of GraT toxin not only
affects operator binding of the GraTA complex, but also its own
activity. The latter is unexpected given that the predicted active
site near His92 is very similar to the active site of HigB and the N-
terminus does not likely contribute catalytically important resi-
dues. While the 22 N-terminal residues are ﬂexible and therefore
might be considered to move towards the active site, this would
likely prevent productive binding to the ribosome.
Therefore, it is more likely that upon ribosome binding this
region would fold in such a way that it facilitates the interaction
between the ribosome and GraT without directly being involved
in catalysis. In line with that, the crystal structure of P. vulgaris
HigB bound to the ribosomal 30S subunit demonstrated that the
ﬁrst N-terminal α-helix of HigB, the very same region that is
unstructured in GraT, is important for HigB recognition of the
16S rRNA in the ribosomal A site28. Given that several sub-
stitutions in HigB α1 decrease HigB toxicity by disturbing its
ribosome binding28, it is reasonable to assume that the N-
terminus of GraT also plays a role in ribosome binding.
In general, disordered regions in proteins may be prone to
degradation. Fast degradation of antitoxins after activation of Lon
during episodes of stress is thought to be facilitated by the pre-
sence of intrinsic disorder7,21 and is crucial for the regulation of
many toxin–antitoxin modules22. In contrast with most anti-
toxins, GraA is a fully ordered protein and, in accordance with
that, is also uncommonly stable and not degraded by Lon or
Clp20. Still, the lifetime of GraA is sensitive to the bacterial
growth phase and ATP levels20, indicating that GraA degradation
can be triggered by certain conditions. Interestingly, MqsA, a fully
structured antitoxin like GraA, is also highly stable under normal
growth conditions but is quickly degraded under oxidative
stress50. Although speculative, the ﬁnding that the toxin GraT
rather than the antitoxin GraA contains the intrinsically dis-
ordered region raises an intriguing possibility of the toxin GraT
being under proteolytic control. Preferential degradation of the
toxin would not only lead to depletion of GraT toxicity but also to
the presence of free antitoxin dimers that prevent transcription.
This would indeed be a strong mechanism that protects Pseu-
domonas putida against accidental graTA activation and might
contribute to the mild and temperature-dependent effects of
GraT toxin18. However, as the stability properties of the GraT and
the trigger for GraA degradation are currently unknown, the
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Fig. 8 The ﬂexible N-terminus of GraT is required for derepression of
the graTA promoter. a β-Galactosidase activities measured in four E. coli
strains. Each strain contains the graT-lacZ transcriptional fusion in
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conditions under which the GraTA module becomes active and
the molecular mechanism behind such activation remain to be
determined.
Methods
Construction of plasmids and strains. Construction of the plasmids and strains
used is detailed in the Supplementary Methods. The different plasmids, strains and
oligonucleotides are listed in Supplementary Table 2.
Protein expression and puriﬁcation. HisGraA and HisGraTA were expressed in
E. coli harboring recombinant pET11c-derived plasmids51. In the case of GraA
alone, it was N-terminally His-tagged, while for the complex GraT it was His-
tagged at the N-terminus and GraA was left untagged. Similar constructs were
generated for Δ22GraTA-his and hisTEV-GraTA by amplifying the modiﬁed
graTA operon with either the GraT_22_Nde/A-his or hisTEV-graT/1585Bam
oligonucleotide pair, respectively, and cloning into the NdeI/BamHI-opened
pET11c. The gene grat_tev_6xhis was chemically synthesized and cloned into NdeI/
NotI-cleaved pET-21b (Supplementary Table 2). In all cases, cells were ﬁrst
grown at 37 °C until optical density (OD) ~0.6 when the temperature was
lowered to 20 °C and protein expression was induced with 0.5 mM IPTG for 16 h.
Cells were lysed in 50 mM Tris, pH 8.0, 250 mM NaCl and 2 mM β-
mercaptoethanol (Buffer A) and protease inhibitors. Puriﬁcations were carried
out by loading each cell lysate supernatant onto a Ni-Sepharose column. The
proteins were eluted with Buffer A plus 500 mM imidazol using a step gradient.
The protein containing fractions were subsequently loaded into a Bio-Rad SEC
70 gel ﬁltration column equilibrated with 50 mM Tris, pH 8.0, 250 mM NaCl
and 2 mM β-Mercaptoethanol. When purifying the proteins for SAXS or ITC,
the 2 mM β-mercaptoethanol was substituted by 2 mM tris(2-carboxyethyl)
phosphine (TCEP).
Preparation of double-stranded DNA. The graTA operator region and its
variants were obtained from single-stranded oligonucleotides purchased from
Sigma-Aldrich. The oligonucleotides were resuspended in water at ~200 μM.
Complementary strands were mixed in a 1:1 ratio to obtain a ﬁnal concentration of
~100 μM of the corresponding double-stranded DNA. The mixture was heated
to 80 °C for 20 min and slowly cooled to room temperature. The formation of all
double-stranded DNA was checked by gel ﬁltration.
Crystallization and structure determination. HisGraA2, hisGraT2A2 and the
hisGraA2/graTA operator complex crystallized in different conditions51 (Supple-
mentary Table 3). All datasets were collected at 100 K at Proxima 1 beamline (Soleil
Synchrotron, Gif-Sur-Yvette, France) at 1.9, 2.2 and 3.8 Å resolution for hisGraA2,
hisGraT2A2 and hisGraA2/graTA operator complex, respectively.
All datasets were processed with XDS52 using the XDSME interface. All the
structures were determined by molecular replacement with the program
PHASER53 from the CCP4 program suite54. For GraA2, the HigA protein from
Coxiella burnetii23 (PDB code: 3TRB) was used as search model. For the structure
of GraT2A2, the previously solved GraA2 structure together with HigB from Proteus
vulgaris16 (PDB code: 4MCX) were used as search models. The reﬁned GraA2
structure and the coordinates of an in silico generated structure of the graTA
operator (AAATTAACGAATAACGTTAAGCATTCAGCTCAT) were used as
search models in the structure determination of the (GraA)2-graTA operator
complex. Several rounds of reﬁnement and model building were performed with
phenix.reﬁne55 from the PHENIX package56 and COOT57. The quality of the
structures was checked with MolProbity58. Data collection and reﬁnement statistics
are shown in Supplementary Table 1.
Small-angle X-ray scattering. SAXS data were collected at SWING beamline
(Soleil Synchrotron, Gif-Sur-Yvette, France). This beamline has a SEC system
before the measuring capillary. SEC will remove possible aggregates rendering a
very homogeneous sample that will then be directly exposed to X-rays for data
collection. All the experiments were performed in 50 mM Tris, pH 8.0, 250 mM
NaCl and 2 mM TCEP as running buffer.
Each protein was run through a Shodex KW402.5-4F at 0.2 ml/min. Scattering
curves covering a concentration range around the peak were normalized and
averaged to obtain the ﬁnal scattering curve. Rg values were derived from the value
of I0 which were obtained by extrapolating to q= 0 using the Guinier
approximation as implemented in ATSAS suite59. The molecular weights of the
different entities were estimated in a concentration independent way using the I0,
Porod volume and Fisher methods.
The use of the dimensionless Kratky plot ((qRg)2I(q)/I(0) vs qRg) is a relatively
easy way to show that a protein is completely folded, partially folded or completely
unstructured60. If a protein is globular it follows Guinier’s law I(q)/I(0)= exp
(−(qRg)2/3). The corresponding dimensionless Kratky plot is a function f(x)=
x2exp(−x2/3), with x= qRg > 0 with maximum of 1.104 at qRg= √3. On the other
hand, an ideally disordered protein follows Debye’s law I(q)/I(0)= 2(x2−1−exp
(−x2))/x4, with x= qRg > 0. In this case the Kratky plot is described by the function
f(x)= 2(x2−1−exp(−x2))/x2 which increases monotonically with an asymptote at f
(x)= 2. Experimentally, globular proteins show a very similar normalized Kratky
plot with a maximum at (√3; 1.1), while partially unstructured proteins show a
maximum shifted to higher values in both axes61.
The ﬁrst 22 amino acids of GraT that are missing in the GraT2A2 structure were
computationally modeled using the program Modeller63. We used the webserver
MultiFoxs62 (http://modbase.compbio.ucsf.edu/multifoxs/) to generate 10,000
conformations of GraTA by sampling the conformational space of the ﬁrst 22
residues while keeping the rest of the complex rigid. Then, theoretical SAXS proﬁle
is calculated for each conformation to further perform a multi-state model
enumeration.
All SAXS data and the corresponding analysis are summarized in
Supplementary Tables 4 to 8.
Isothermal titration calorimetry. All ITC titrations were carried out in an iTC200
calorimeter (GE Healthcare). Prior to the measurements, GraA2, GraT2A2,
Δ22GraT2A2 and the various dsDNA fragments were dialyzed against 50 mM Tris
pH 8.0, 250 mM NaCl and 2 mM β-Mercaptoethanol to minimize buffer mismatch.
For GraA2 and Δ22GraT2A2 the concentrations in the 200 μL cell were 20 and
18 μM, respectively. Several injections of 2 μL of graTA operator at 90 μM were
used. The concentration of GraT2A2 was 165 μM and graTA operator was injected
in 1 μL volumes at 989 μM. All the titrations were performed at 25 °C. Raw data
were integrated and corrected for the buffer dilution heat effects using the
MicroCal Origin software to obtain the enthalpy change per mole of added ligand
corrected for the buffer dilution effects. Calorimetric isotherms were analyzed
using a model describing a cooperative binding of the protein species to the graTA
operator:
GraA2+1/2 operator → 1/2 GraA2-operator.
Model-adjusted parameters ΔGA (free energy of association per mole of ligand)
and ΔHA (standard enthalpies of association per mole of ligand) were obtained
through least-square ﬁtting as implemented in MicroCal Origin 7.0 and
SEDPHAT64. Equilibrium association constants KA reported in the text were
calculated from the corresponding ΔGA.
Electrophoretic mobility shift assay. Assays were performed by mixing different
protein concentrations (0, 0.625, 1.25, 2.5, 5, 10 and 20 μM) and a ﬁxed graTA
operator concentration (5 μM) to obtain the following protein/DNA molar ratios:
0:1, 1:8, 1:4, 1:2, 1:1, 2:1 and 4:1. The mixtures were incubated at room temperature
for 30 min and loaded onto a native 6% polyacrylamide gel prepared with TBE
(Tris/Borate/EDTA) buffer. The gel was run embedded in ice with pre-cooled TBE
as running buffer (the ﬁrst 10 min at 180 V followed by 25 min at 120 V). The
DNA was stained with ethidium bromide and visualized using a Proxima 10 Phi
(ISOGEN Lifescience) apparatus.
TEV protease digestion. A TEV cleavage site (GNLYPQ|G) was inserted between
the 6xHis tag and the second amino acid of GraT. His-TEV-GraT2A2 was
incubated with hisTEV overnight at a molar ratio of 5:1. The reaction product
was incubated for 10 min with Ni-sepharose resin and centrifuged at 5000 rpm.
hisTEV, the 6xHis containing peptides and uncleaved protein bound to the resin,
while tag-less GraT2A2 was collected from the supernatant. Completion of the
reaction was conﬁrmed by sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE) and western blot using a anti-Histidinge-tag antibody.
Native mass spectrometry. Samples of GraA2-DNA for native ion mobility mass
spectrometry65 were prepared by mixing together GraA2 dimer and DNA duplex in
40 mM aqueous ammonium acetate pH 7 to provide complexes with 1:1, 2:1 and
4:1 stoichiometry, and this each time with a ﬁnal concentration of GraA2 dimer
of 20 μM. The samples were introduced into the mass spectrometer using nano-
electrospray ionization using in-house prepared gold-coated glass capillaries and
a spray voltage of +1.6 kV. Spectra were recorded on a traveling wave Q-TOF
instrument (Synapt G2, Waters, Manchester, UK) tuned for transmission of large,
native protein assemblies. Voltages used were sampling cone 50 V, trap collision
cell 75 V and trap DC bias 45 V. Pressures in subsequent stages of the instrument
were 5 mbar, 2.86 × 10−2 mbar and 3.45 mbar for source, trap cell and ion mobility
cell, respectively. Spectra were externally calibrated using a 10 mg/mL solution of
cesium iodide. Analyses of the acquired spectra were performed using Masslynx
version 4.1 (Waters, Manchester, UK).
mRNA degradation assay. E. coli MG1655 Δ10 TA was transformed with either
pBBRlacItac, pBBRlacItac-graTA or pBBRlacItac-Δ22graT. Overnight cultures
were diluted into 50 mL fresh LB medium to OD580 of ~0.1 and grown at 30 °C.
After 1 h, temperature was shifted to 20 °C. After 30 min, the cultures were split in
two parts and 0.5 mM IPTG was added to one parallel. Then, 1.5 mL of cultures
were harvested right before IPTG addition at 30 min and 60 min post induction.
Cells were pelleted and frozen in liquid N2. RNA was extracted using RNAzol®
RT (Molecular Research Center, Inc.). For primer extension, the oligonucleotide
lpp_ec was radiolabelled using [γ-32P]ATP (Hartmann Analytic) and the reactions
were carried out using AMV (avian myeloblastosis virus) reverse transcriptase
(Promega). The reference sequence was ampliﬁed from the E. coli genome with
lpp_ec and lpp_ec_ees and sequenced with radiolabelled lpp_ec using the
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SequenaseTM Version 2.0 DNA Sequencing Kit (Affymetrix). The resulting frag-
ments were separated on a 7% polyacrylamide-urea gel and visualized on a
Typhoon phosphoimager (GE Healthcare).
Temperature-sensitive growth assay. For assaying the in vivo functionality of
GraT and its N-terminal truncation derivative Δ22GraT, the P. putida wild-type
PaW85, ΔgraA and their Δ22graT derivative strains were grown overnight in LB
medium. Overnight cultures were diluted 100-fold, spotted onto LB plates as 5 μL
drops and incubated at 20 °C, 25 °C and 30 °C for 24 h.
β-Galactosidase assay. E. coli DH5α cells harboring graT-lacZ transcriptional
fusion in plasmid p9TT1586 were transformed with one of the plasmids for
expression of GraTA proteins (plasmids pBBRlacItac-graA, pBBRlacItac-graTA
and pBBRlacItac-Δ22graTA) or with an empty plasmid pBBRlacItac. At least three
individual fresh transformant colonies were inoculated into LB media containing
gentamycin (ﬁnal concentration 10 μg/mL) and ampicillin (100 μg/mL). For
induction of GraTA proteins, 10 μM IPTG was added and bacteria were grown for
20 h at 37 °C. β-Galactosidase activities were measured by a protocol described
previously18. Expression of GraA and GraT proteins was veriﬁed by western blot
analysis. For that, proteins were separated on 10% Tricine-SDS-PAGE and trans-
ferred to polyvinylidene diﬂuoride membranes. GraA and GraT were detected by
probing membranes with anti-GraA and anti-GraT polyclonal antibodies, respec-
tively. The blots were treated with alkaline phosphatase-conjugated anti-mouse
immunoglobulin G and developed using bromochloroindolyl phosphate/nitro blue
tetrazolium.
Data availability
All the crystallographic structural data has been deposited into the Protein Data Bank
(www.rcsb.org) with the following accession codes: 6F8H (GraA2), 6F1X (GraA2/DNA)
and 6F8S (GraA2T2). The scattering data produced by the SAXS were deposited at the
www.sasbdb.org database with the accession codes: SASDE68 (GraA-Operator complex),
SASDE58 (GraTA complex), SASDE48 (GraT). The raw data ﬁles supporting Figs. 6 and
8a are included in the source data ﬁle. Other data are available from the corresponding
authors upon reasonable request.
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